Many women going through menopause use oestrogen patches, a menopausal hormone therapy/hormone replacement treatment (MHT/HRT) used to manage menopausal symptoms.
There has been a shortage of these products this year, including Estradot (oestrogen only) and Estalis (combined oestrogen and progestogen). Jean Hailes for Women's Health featured in The Sydney Morning Herald and The Age in a story in April about the shortage of oestrogen patches.
Supplies are now resuming. With questions still being raised about the shortage, however, we asked Jean Hailes Medical Director Dr Elizabeth Farrell and Jean Hailes endocrinologist Dr Sonia Davison for some further advice.
When are supplies expected to return to normal?
Novartis, a pharmaceutical company that supplies some oestrogen patches, advised Jean Hailes that its stock of Estradot and Estalis is now available.
What happens if my preferred product is still in short supply?
There are alternative MHT/HRT options available, including a topical gel or substituting with another patch, but it's best to make an appointment and talk to your health professional to work out what's appropriate for you.
I'm a health practitioner, where can I find reliable information on MHT/HRT products?
- The Australasian Menopause Society has an excellent guide to equivalent MHT/HRT doses and should be consulted for further guidance as to other products that may be used.
- Jean Hailes has a Menopause health professional tool.
- Also refer to the Jean Hailes webinar for health professionals, Initiating menopausal hormone therapy/hormone replacement therapy.
- For further information on menopause management, download A Practitioner's Toolkit for the Management of the Menopause, developed by the Women's Health Research Program at Monash University.
Women and health professionals can also visit the Department of Health website for more supply information. To learn more about menopause and managing menopausal symptoms, please visit the Jean Hailes Menopause webpages.